What Researchers Did
Researchers reviewed the medical records of 172 patients treated with radiation therapy for salivary gland malignancies over a 12-year period to evaluate osteoradionecrosis.
What They Found
Out of 172 patients, 7 (4%) developed osteoradionecrosis (ORN) with a median latency of 19 months. Among these 7 patients, 4 required major surgery, highlighting ORN as a significant late effect despite a lower incidence compared to other head and neck cancers (4% vs 8-14%).
What This Means for Canadian Patients
Canadian patients undergoing radiation therapy for salivary gland malignancies should be aware of the 4% risk of developing osteoradionecrosis. Early detection and management are crucial, as a significant number of these cases may require major surgical intervention.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
A limitation of this study is its retrospective design and the relatively small number of osteoradionecrosis cases (7 patients) observed.